Broadly Protective Protein-Based Pneumococcal Vaccine Composed of Pneumolysin Toxoid–CbpA Peptide Recombinant Fusion Protein

A century of pneumococcal vaccination research in humans

(2012) J.D. Grabenstein et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pediatric Invasive Pneumococcal Disease in the United States in the Era of Pneumococcal Conjugate Vaccines

(2012) T. Q. Tan   CLINICAL MICROBIOLOGY REVIEWS

The burden of nonencapsulated Haemophilus influenzae in children and potential for prevention

(2012) Despoina Gkentzi et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Neutralizing Antibodies Elicited by a Novel Detoxified Pneumolysin Derivative, PlyD1, Provide Protection against Both Pneumococcal Infection and Lung Injury

(2012) Danielle Salha et al.   INFECTION AND IMMUNITY

Physical Characterization and Formulation Development of a Recombinant Pneumolysoid Protein-Based Pneumococcal Vaccine

(2012) Lei Hu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Mapping the Laminin Receptor Binding Domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2

(2012) Noha M. Abouseada et al.   PLoS One

Rapid Pneumococcal Evolution in Response to Clinical Interventions

(2011) N. J. Croucher et al.   SCIENCE

Only two amino acids are essential for cytolytic toxin recognition of cholesterol at the membrane surface

(2010) A. J. Farrand et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Laminin receptor initiates bacterial contact with the blood brain barrier in experimental meningitis models

(2009) Carlos J. Orihuela et al.   JOURNAL OF CLINICAL INVESTIGATION

Protection against Nasopharyngeal Colonization by Streptococcus pneumoniae Is Mediated by Antigen-Specific CD4+ T Cells

(2008) K. Trzcinski et al.   INFECTION AND IMMUNITY